These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2441788)

  • 81. Usefulness of a prevoiding transabdominal sonographic bladder scan for uroflowmetry in patients involved in clinical studies of benign prostatic hyperplasia.
    Dicuio M; Creti S; Di Campli A; Dipietro R; Mannini D; Nanni G; Dahlstrand C; Cuzzocrea DE
    J Ultrasound Med; 2003 Aug; 22(8):773-6. PubMed ID: 12901403
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Detrusor underactivity in men with lower urinary tract symptoms/benign prostatic obstruction: characterization and potential impact on indications for surgical treatment of the prostate.
    Rademakers KL; van Koeveringe GA; Oelke M
    Curr Opin Urol; 2016 Jan; 26(1):3-10. PubMed ID: 26574876
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.
    Tanaka Y; Masumori N; Itoh N; Sato Y; Takahashi A; Ogura H; Furuya S; Tsukamoto T
    J Urol; 2002 Jun; 167(6):2492-5. PubMed ID: 11992065
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Clinical significance of intravesical prostatic protrusion in patients with benign prostatic enlargement.
    Keqin Z; Zhishun X; Jing Z; Haixin W; Dongqing Z; Benkang S
    Urology; 2007 Dec; 70(6):1096-9. PubMed ID: 18158025
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Applying bladder outlet obstruction number to predict bladder outlet obstruction of benign prostatic hyperplasia].
    Zhang P; Wu ZJ; Yang Y; Zhang XD
    Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(15):1156-9. PubMed ID: 19094679
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The role of urodynamic investigation in the assessment of benign prostatic hypertrophy.
    McGuire EJ
    J Urol; 1992 Oct; 148(4):1133-6. PubMed ID: 1383572
    [No Abstract]   [Full Text] [Related]  

  • 87. Noninvasive techniques for the measurement of isovolumetric bladder pressure.
    Blake C; Abrams P
    J Urol; 2004 Jan; 171(1):12-9. PubMed ID: 14665833
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Interrelation of hyperactivity of bladder and infravesical obstruction in patients with benign prostate hyperplasia].
    Bablumyan A
    Georgian Med News; 2010 Dec; (189):7-11. PubMed ID: 21252402
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Decrease of ultrasound estimated bladder weight during tamsulosin treatment in patients with benign prostatic enlargement.
    Sironi D; Levorato CA; Deiana G; Borgonovo G; Belussi D; Ranieri A; Lembo A
    Arch Ital Urol Androl; 2002 Jun; 74(2):90-4. PubMed ID: 12161944
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Bladder mechanoreceptor changes after artificial bladder outlet obstruction in the anesthetized rat.
    Zeng J; Xie K; Jiang C; Mo J; Lindström S
    Neurourol Urodyn; 2012 Jan; 31(1):178-84. PubMed ID: 22038729
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The long-term effect of alfuzosin in patients with lower urinary tract symptoms suggestive of benign prostate hyperplasia: evaluation of voiding and storage function with respect to bladder outlet obstruction grade and contractility.
    Song K; Choo MS; Lee KS; Han JY; Lee YS; Kim JC; Cho JS
    Urology; 2011 May; 77(5):1177-82. PubMed ID: 21256567
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Natural history of post-void residual urine volume over 5 years in community-dwelling older men: The Concord Health and Ageing in Men Project.
    Noguchi N; Chan L; Cumming RG; Blyth FM; Handelsman DJ; Waite LM; Le Couteur DG; Naganathan V
    Neurourol Urodyn; 2018 Mar; 37(3):1068-1073. PubMed ID: 28940729
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Comparative accuracy of the Lilium α-200 portable ultrasound bladder scanner and conventional transabdominal ultrasonography for postvoid residual urine volume measurement in association with the clinical factors involved in measurement errors.
    Yamaguchi Y; Kamai T; Kobayashi M
    Neurourol Urodyn; 2021 Jan; 40(1):183-192. PubMed ID: 33022795
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Measurement of residual urine volume using a portable ultrasound instrument.
    Fuse H; Yokoyama T; Muraishi Y; Katayama T
    Int Urol Nephrol; 1996; 28(5):633-7. PubMed ID: 9061421
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Efficacy and problems of bladder volume measurement using portable three dimensional ultrasound scanning device--in particular, on measuring bladder volume lower than 100ml].
    Oh-Oka H; Nose R
    Nihon Hinyokika Gakkai Zasshi; 2005 Sep; 96(6):601-9. PubMed ID: 16218402
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The accuracy of a hand-held real time ultrasound scanner for estimating bladder volume.
    Ravichandran G; Fellows GJ
    Br J Urol; 1983 Feb; 55(1):25-7. PubMed ID: 6824861
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Renal and bladder function recovery after prostatectomy in patients with a chronic residual urine of above 1,000 ml.
    Nissenkorn I; Savion M; Servadio C
    Eur Urol; 1988; 14(6):434-6. PubMed ID: 2460354
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Ultrasound as an alternative to intravenous urography in prostatism.
    Fidas A; Mackinlay JY; Wild SR; Chisholm GD
    Clin Radiol; 1987 Sep; 38(5):479-82. PubMed ID: 2444381
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The day-to-day variation (test-retest reliability) of residual urine measurement.
    Dunsmuir WD; Feneley M; Corry DA; Bryan J; Kirby RS
    Br J Urol; 1996 Feb; 77(2):192-3. PubMed ID: 8800883
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Serial residual volumes in men with prostatic hypertrophy.
    Birch NC; Hurst G; Doyle PT
    Br J Urol; 1988 Dec; 62(6):571-5. PubMed ID: 2464395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.